Compare Align Technology, Inc. (ALGN) vs Icl Group Ltd (ICL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Icl Group Ltd — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Icl Group Ltd trades at $4.87 (market cap $6.30B). The key difference: Align Technology, Inc. is far larger — about 2× Icl Group Ltd's market cap, and Icl Group Ltd pays a 3.93% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | ICL | |
|---|---|---|
Market Cap | $12.86B | $6.30B |
Sector | Health | Basic Materials |
52-Week High | $207.19 | $7.07 |
52-Week Low | $124.88 | $4.80 |
Enterprise Value | $11.92B | $8.87B |
Dividend Yield | — | 3.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
ICL trades at $4.85, unchanged on the day, with a bearish technical signal from moving averages. The company reported Q1 2026 earnings of $0.11 per share, beating expectations, and recently completed an $800 million senior notes offering. Revenue for 2025 was $7.15 billion, with a net income margin of 3.52% and a P/E ratio of 23.1. Analyst consensus is entirely Hold, with no Buy or Sell ratings among the four covering firms.
ICL faces headwinds from declining profit margins and elevated raw material costs, but operational improvements and raised 2026 EBITDA guidance offer some upside. Key risks include geopolitical tensions and foreign exchange volatility. The stock's current valuation appears fair, with limited near-term catalysts given the neutral analyst sentiment and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Icl Group Ltd
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Read more on ICL →
